Frankis Almaguel, MD joins Phillip Koo, MD for the ongoing lecture series that is sponsored by the Society of Nuclear Medicine and Molecular Imaging (SNMMI). Dr. Almaguel speaks to therapeutic interventions based on Prostate-specific membrane antigen (PSMA) findings that have the potential of changing the treatment of prostate cancer and the impact of personalized care in this disease space. Frankis highlights several trials supporting PSMA as a promising target in prostate cancer. They also highlight the role bone scans and CT scans will have in the future now that we have next-generation imaging tools, such as PSMA-PET, and the significant potential of targeted therapies with PSMA. Biographies:
Frankis Almaguel, MD, Ph.D., Director, Molecular Imaging and Therapeutics, Loma Linda University Cancer Center, Center for Health Disparities and Molecular Medicine
Phillip J. Koo, MD, Division Chief of Diagnostic Imaging at the Banner MD Anderson Cancer Center in Arizona.